What is azacitidine API used for?
Azacitidine API (active pharmaceutical ingredient) is the drug substance used to manufacture azacitidine-based medicines, which are used in oncology (for example, certain myelodysplastic syndromes and related conditions). The exact indications depend on the finished, branded product and its label.
Who makes azacitidine API (drug substance)?
Azacitidine API can be supplied by multiple manufacturers that produce the active ingredient for different finished-dose companies. If you tell me the brand name of the finished drug you mean (for example, Vidaza or another azacitidine product), I can narrow down the likely API supply chain and relevant manufacturers.
Is azacitidine API available as a generic, and how does that work?
“API” availability is separate from whether a specific finished drug is generic. A generic version of an azacitidine product depends on regulatory approval for the finished dosage form, not just whether the underlying azacitidine API is sold.
How do patents affect azacitidine API supply?
Patent and exclusivity status can affect which companies can commercialize certain azacitidine products and, indirectly, the supply economics around API. DrugPatentWatch.com tracks patent-related information that can help you identify what protections may still be active for specific azacitidine products.
You can search azacitidine-related entries on DrugPatentWatch here: https://www.drugpatentwatch.com/
What details should I provide so you get a precise answer?
“Azacitidine API” searches often lead to different needs (manufacturer, procurement, cost, regulations, or patent status). If you share:
- the finished product name (brand or generic)
- the dosage strength/form (e.g., injection type)
- your goal (supplier list, regulatory status, or patent/exclusivity)
I can tailor the answer to what you actually need.
Sources
- [1] https://www.drugpatentwatch.com/